#1 Clinical Trials Search in Europe by CTIN

Our offer Newsroom

Find a treatment: By disease

Search all trials

Find therapies in clinical trials near you – page 20

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Breast cancer+2

Not recruiting

Registered drugNo placebo

Gedatolisib plus drug combination for HR‑positive, HER2‑negative advanced breast cancer patients whose disease progressed after CDK4/6 inhibitor therapy

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Alpelisib

Contact Research Centre

Dementia Alzheimer's type

Not recruiting

Registered drug

Study of Trontinemab Compared to Placebo for Patients with Early Symptomatic Alzheimer's Disease

Registered drug

Italy

Participants:18–64 years · 65+ years
Substances:Florbetaben (18F)

Contact Research Centre

Dementia Alzheimer's type

Not recruiting

Registered drug

A study testing trontinemab compared to placebo in patients with early Alzheimer's disease including mild cognitive impairment and mild dementia

Registered drug

Italy

Participants:18–64 years · 65+ years
Substances:Florbetaben (18F)

Contact Research Centre

Dementia Alzheimer's type

Not recruiting

InvestigationalNo placebo

A Study to Test the Long-term Safety and Benefits of GSK4527226 in Patients with Early Alzheimer's Disease

InvestigationalNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Gsk4527226

Contact Research Centre

Congenital cystic kidney disease

Not recruiting

Investigational

Study of ABBV-CLS-628 to evaluate safety and effectiveness in adults with Autosomal Dominant Polycystic Kidney Disease

Investigational

Italy

Participants:18–64 years
Substances:ABBV-CLS-628

Contact Research Centre

Idiopathic pulmonary fibrosis

Not recruiting

Registered drug

Study on the Effects of CAL101 for Patients with Idiopathic Pulmonary Fibrosis

Registered drug

Italy

Participants:18–64 years · 65+ years
Substances:CAL101

Contact Research Centre

Hidradenitis

Not recruiting

Registered drug

Study on the Effects of Remibrutinib for Adults with Moderate to Severe Hidradenitis Suppurativa

Registered drug

Italy

Participants:0–17 years · 18–64 years · 65+ years
Substances:Remibrutinib

Contact Research Centre

Sickle cell anaemia with crisis

Not recruiting

Investigational

Study on the Safety and Effectiveness of CSL889 for Adults and Adolescents with Sickle Cell Disease During Painful Crises

Investigational

Italy

Participants:0–17 years · 18–64 years · 65+ years
Substances:HEMOPEXIN, HUMAN

Contact Research Centre

Interstitial lung disease+1

Not recruiting

Investigational

Study to Test if Nerandomilast (BI 1015550) Helps Patients with Interstitial Lung Disease Related to Rheumatic Diseases

Investigational

Italy

Participants:18–64 years · 65+ years
Substances:1-[[(5R)-2-[4-(5-Chloro-2-Pyrimidinyl)-1-Piperidinyl]-6,7- Dihydro-5-Oxidothieno[3,2-D]Pyrimidin-4- Yl]Amino]-Cyclobutanemethanol

Contact Research Centre

Chronic lymphocytic leukaemia

Not recruiting

InvestigationalNo placebo

Study on the Effectiveness and Safety of Sonrotoclax and Zanubrutinib for Adults with Untreated Chronic Lymphocytic Leukemia

InvestigationalNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Zanubrutinib

Contact Research Centre

Triple negative breast cancer

Not recruiting

Registered drugNo placebo

Study on the Effectiveness and Safety of Datopotamab Deruxtecan Compared to Chemotherapy in Adults with Advanced Triple-negative Breast Cancer

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Capecitabine

Contact Research Centre

Breast cancer

Not recruiting

Registered drugNo placebo

Study on Chemotherapy and Aromatase Inhibitors (Exemestane, Letrozole, Anastrozole) for Post-Menopausal Patients with Early Breast Cancer

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Anastrozole

Contact Research Centre

Explore other searches

Helpful resources

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.